AlphaCrest Capital Management’s CONMED CNMD Stock Holding History

AlphaCrest Capital Management’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-4,079	Closed	-$327K	–	242
2022 Q3	$327K	Sell	4,079 -9	-0.2%	-$849	0.02%	1120
2022 Q2	$391K	Buy	4,088 +1,778	+77%	+$213K	0.02%	1030
2022 Q1	$343K	Buy	+2,310	New	+$323K	0.02%	1063
2021 Q4	–	Sell	-1,672	Closed	-$219K	–	1374
2021 Q3	$219K	Buy	+1,672	New	+$219K	0.01%	1196
2020 Q3	–	Sell	-3,643	Closed	-$262K	–	1100
2020 Q2	$262K	Sell	3,643 -5,043	-58%	-$351K	0.04%	692
2020 Q1	$497K	Buy	8,686 +3,361	+63%	+$310K	0.06%	573
2019 Q4	$595K	Buy	+5,325	New	+$567K	0.05%	671
2019 Q3	–	Sell	-8,500	Closed	-$727K	–	1258
2019 Q2	$727K	Buy	+8,500	New	+$699K	0.06%	544

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

AlphaCrest Capital Management's CNMD Position: Q4 2022 in Review

AlphaCrest Capital Management sold out of CONMED (CNMD) in Q4 2022, closing a stake of 4,079 shares — an estimated $327K sold.

AlphaCrest Capital Management first reported a position in CNMD in Q2 2019 and held it in 8 quarters. The position peaked at $727K in Q2 2019. 239 funds tracked by Wall St. Rank hold CNMD as of Q4 2022.

AlphaCrest Capital Management reported no remaining CONMED position as of Q4 2022 after selling out during the quarter.
AlphaCrest Capital Management sold 4,079 CONMED shares in Q4 2022, an estimated $327K.
AlphaCrest Capital Management first reported a position in CONMED in Q2 2019 and held it in 8 quarters.
AlphaCrest Capital Management's CONMED position peaked at $727K in Q2 2019.
239 funds tracked by Wall St. Rank held CONMED as of Q4 2022.

Based on AlphaCrest Capital Management's 13F filing for Q4 2022.